News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
20
2023
-
06
2023 Star Club | Linuo Pharmaceutical won the "Retail Pharmacy Popular Brand Enterprise" award!
Classification：
News
On June 17, the China Pharmaceutical Circulation Trade Conference and the Third World Pharmaceutical Retail Industry Conference (referred to as the "Third Star Conference") grandly released the "Retail Pharmacy Popular Brand Enterprise" award. Keyuan Pharmaceutical (Shenzhen Stock Exchange stock code 301281) subsidiary Linuo Pharmaceutical stood out and won this award! The purpose of this award is to discover enterprises with influence, sales force, competitiveness and attention in the field of pharmaceutical retail, to encourage products to drive brands, to lead the market with brands, and to promote the continuous upgrading of China's pharmaceutical industry on the road of high-quality development!
Since its establishment more than 20 years ago, Linuo Pharmaceutical, a subsidiary of Keyuan Pharmaceutical (Shenzhen Stock Exchange Stock Code 301281), has always adhered to the corporate purpose of serving the country through industry, pursuing excellence, serving the society, and benefiting mankind, and has worked hard to implement the "Healthy China" strategy with practical actions. Escort the national economy and the people's livelihood, and contribute to the cause of human health!
Last article
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China